Lanean...
IDH1 mutant negative ganglioglioma progression to gliosarcoma
Gangliogliomas comprise of less than 1% of all primary brain tumours. Malignant transformation is rare. Correspondingly, secondary gliosarcomas, especially in the absence of previous irradiation exposure is too, exceedingly rare. Recent evidence supports the use of mutant IDH1 testing in suspected a...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2017-09-01
|
| Saila: | Interdisciplinary Neurosurgery |
| Sarrera elektronikoa: | http://www.sciencedirect.com/science/article/pii/S2214751916300809 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|